MADRID, Nov 19 (Reuters) - Canadian investment fund
Brookfield said on Tuesday it is considering making an
public offer for Spanish pharma firm Grifols implying
a valuation 6.45 billion euros ($6.81 billion) or 10.50 euros
per A share.
The price indication is non-binding, Brookfield said in a
filing to the Spanish stock market regulator.
($1 = 0.9472 euros)